EAEbunoluwa Aderonke Adejuyigbe

Ebunoluwa Aderonke Adejuyigbe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ebunoluwa Aderonke Adejuyigbe has a total of 170 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) trial—rationale for the selected lower steroid dose

    by The Who Action Trials Collaborators, Ebunoluwa Aderonke Adejuyigbe, Olubukola Adeponle Adesina, Salahuddin Ahmed, Shabina Ariff, Adejumoke Idowu Ayede, Rajiv Bahl, Abdullah H. Baqui, Harish Chellani, Saleha Begum Chowdhury, et al.

  • Open Access

    The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries

    by Who Action Trials Collaborators, Temitope Adesiji Adegboyega, Ebunoluwa Aderonke Adejuyigbe, Olubukola Adeponle Adesina, Babalola Adeyemi, Salahuddin Ahmed, Francis Akinkunmi, Jalemba Aluvaala, Henry Anyabolu, Shabina Ariff, et al.

    Background: Preterm birth complications are the leading cause of newborn and under-5 mortality. Over 85% of all preterm births occur in the late preterm period, i.e. between 34 and < 37 weeks of gestation. Antenatal corticosteroids (ACS) prevent mortality and respiratory morbidity when administered to women at high risk of an early preterm birth, i.e. < 34 weeks’ gestation. However, the benefits and risks of ACS in the late preterm period are less clear; both guidelines and practices vary between settings. Emerging evidence suggests that the benefits of ACS may be achievable at lower doses than presently used. This trial aims to determine the efficacy and safety of two ACS regimens compared to placebo, when given to women with a high probability of late preterm birth, in hospitals in low-resource countries. Methods: WHO ACTION III trial is a parallel-group, three-arm, individually randomized, double-blind, placebo-controlled trial of two ACS regimens: dexamethasone phosphate 4 × 6 mg q12h or betamethasone phosphate 4 × 2 mg q 12 h. The trial is being conducted across seven sites in five countries—Bangladesh, India, Kenya, Nigeria, and Pakistan. Eligible women are those with a gestational age between 34 weeks 0 days and 36 weeks 5 days, who have a high probability of preterm birth between 12 h and 7 days (up to 36 weeks 6 days gestation). The primary outcome is a composite of stillbirth or neonatal death within 72 h of birth or use of newborn respiratory support within 72 h of birth or prior to discharge from hospital, whichever is earlier. Secondary outcomes include safety and health utilization measures for both women and newborns. The sample size is 13,500 women. Discussion: This trial will evaluate the benefits and possible harms of ACS when used in women likely to have a late preterm birth. It will also evaluate a lower-dose ACS regimen based on literature from pharmacokinetic studies. The results of this trial will provide robust critical evidence on the safe and appropriate use of ACS in the late preterm period internationally. Trial registration: ISRCTN11434567. Registered on 7 June 2021.


  • Open Access

    Evaluation of impact of continuous KMC initiated immediately after birth compared to KMC initiated after stabilization, in newborns with birth weight 1.0 to <1.8 kg on neurodevelopmental outcomes: protocol for a follow-up study

    by Ea Adejuyigbe, I Agyeman, P Anand, Hc Anyabolu, S Arya, En Assenga, S Badhal, Nw Brobby, Hk Chellani, N Chopra, et al.

    Background:Preterm birth or low birth weight is the single largest cause of death in newborns, but the mortality can be reduced through newborn care interventions, including Kangaroo Mother Care (KMC). Previously, a multi-country randomized controlled trial, coordinated by the World Health Organization reported a significant survival advantage with initiation of continuous KMC immediately after birth compared with initiation of continuous KMC a few days after birth when the baby is considered clinically stable.Whether the survival advantage would lead to higher rates of neurodevelopmental morbidity, or the immediate KMC will have a beneficial effect on cognitive development also, has not been investigated. We therefore propose to test the hypothesis that low-birth-weight infants exposed to immediate KMC will have lower rates of neurodevelopmental impairment in comparison to traditional KMC-treated infants, by prospectively following up infants already enrolled in the immediate KMC trial, for the first two years of life, and assessing their growth and neurodevelopment. Methods:This prospective cohort study will enroll surviving neonates from the main immediate KMC trial. The main trial as well as this follow-up study are being conducted in five low- and middle-income income countries in South Asia and sub-Saharan Africa. The sample size for comparison of risk of neurodevelopmental impairment is a total of about 2200 neonates. The primary outcomes will include rates of cerebral palsy, hearing impairment, vision impairment, mental and motor development, and epilepsy and will be assessed by the age of three years. The analysis will be by intention to treat.DiscussionImmediate KMC can potentially reduce low-birth-weight associated complications such as respiratory disease, hypothermia, hypoglycemia and infection that can result in impaired neurocognitive development. Neuroprotection may also be mediated by improved physiological stabilization that may lead to better maturation of neural pathways, reduced risk of hypoxia, positive parental impact, improved sleep cycles and improved stress responses. The present study will, therefore, help in evaluating the overall impact of KMC by investigating the long-term effect on neurodevelopmental impairment in the survivors.Trial registrationClinical Trials Registry-India: CTRI/2019/11/021899 on 06 November 2019

  • Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial

    by Antoinette Tshefu, Adrien Lokangaka, Serge Ngaima, Cyril Engmann, Fabian Esamai, Peter Gisore, Adejumoke Idowu Ayede, Adegoke Gbadegesin Falade, Ebunoluwa A Adejuyigbe, Chineme Henry Anyabolu, et al.


  • Open Access

    Maternal and perinatal health research priorities beyond 2015: an international survey and prioritization exercise

    by Joao Paulo Souza, Mariana Widmer, Ahmet Metin Gülmezoglu, Theresa Anne Lawrie, Ebunoluwa Aderonke Adejuyigbe, Guillermo Carroli, Caroline Crowther, Sheena M Currie, Therese Dowswell, Justus Hofmeyr, et al.

    Maternal mortality has declined by nearly half since 1990, but over a quarter million women still die every year of causes related to pregnancy and childbirth. Maternal-health related targets are falling short of the 2015 Millennium Development Goals and a post-2015 Development Agenda is emerging. In connection with this, setting global research priorities for the next decade is now required.


  • Feeding and care of low‐birthweight babies in two rural communities in south‐western Nigeria

    by Ebunoluwa A. Adejuyigbe, Adetanwa I. Odebiyi, Olabisi Aina, Sina Bamiwuye

    The aim of this cross‐sectional study was to highlight the sociocultural beliefs and practices relating to the care and feeding of low‐birthweight (LBW) babies in two rural communities in the south‐west of Nigeria. Data from 60 mothers and their newborns and community care providers were collected using qualitative instruments. The 60 mothers [30 mothers of LBW and 30 of normal‐birthweight (NBW) infants] were identified through key informants, snowball approach and information obtained from community healthcare providers. The mean weight at recruitment of the LBW and NBW babies studied was 1680 ± 440 and 2990 ± 450 g respectively. Only two of the 60 mothers in the study delivered in orthodox health facilities, because in most cases these facilities were unaffordable, inaccessible and incompatible with rural lifestyles/beliefs. Most of the mothers believed that exclusive breastfeeding was not adequate for the LBW babies, and so herbal mixtures believed to accelerate growth were given in addition to breast milk. The use of forced hand‐feeding and feeding bottles was universal among the mothers of LBW babies in order to ‘increase the volume of feeds the baby gets’. Herbal dressing was used for cord and anterior fontanel care, while the babies were kept warm by using extra clothing, lighted lanterns and shutting of the windows. Five (16.7%) LBW infants and 1 (3.3%) NBW baby died, while 12 (40%) LBW, compared with 4 (13.3%) NBW infants, were hospitalized during the study. The findings of this study serve to identify the cultural beliefs and values around the care of LBW infants. Interventions designed to improve neonatal survival must therefore, take cognizance of these beliefs, customs and practices, in order to ensure effective and proper care of the LBW infants.


  • Oro-facial lesions in human immunodeficiency virus infected children in Ile-Ife, Nigeria

    by Foluso Owotade, Morenike Folayan, Michael Adedigba, Henry Anyabolu, Ebunoluwa Adejuyigbe

    The aim of this cross-sectional study was to determine the prevalence and types of oro-facial lesions and their relationship with the degree of immune suppression in human immunodeficiency virus (HIV)-infected children. This was compared with the prevalence among healthy HIV-negative children. The study was carried out in a tertiary institution in Southwestern Nigeria from May 2005 to March 2006. None of the children in the study had ever been treated with antiretroviral drugs. Thirty-four (87.2%) of 39 HIV infected children and two (9.5%) of the 21 HIV-uninfected children had oro-facial lesions (Fisher's exact, P = 0.0001). In the HIV-infected children, lymphadenopathy was the commonest lesion (82.1%) followed by oral candidiasis (43.6%), gingivitis (25.6%) and bilateral parotid enlargement (25.6%). The most common form of candidiasis was pseudomembranous. All the oro-facial lesions were more common in children with severe immune suppression and were not related to the age, gender or socioeconomic class of the children. It is therefore concluded that there is a high prevalence of oro-facial lesions in HIV-infected children in this study particularly in those with severe immune suppression. These lesions could serve as surrogate markers of HIV infection and aid in initiating prompt diagnosis where routine laboratory investigation for all children at risk is economically not feasible.

  • Open Access

    Bacterial Isolates in the Sick Young Infant in Ile-Ife, Nigeria

    by E. A. Adejuyigbe, A. K. Ako-Nai, B. Adisa

    This prospective study was carried out to determine the bacterial pathogens and their antibiotic sensitivity profile in the sick young infant. All consecutive young infants with features suggestive of infection seen over 5 months at a Comprehensive Health Centre in Ile-Ife, were screened for septicaemia and local bacterial infections. Of the 121 sick young infants screened for infection, 94 (77.7 per cent) had confirmed bacterial infection and 54 (57.4 per cent) of the 94 had confirmed septicaemia. Gram-positive organisms were the commonest bacterial isolates accounting for 204 (81.6 per cent) of the 250 isolates in this study. Staphylococcus aureus was the most frequent organism accounting for 61.2 per cent of all isolates. Gram-negative organisms accounted for 46 (18.4 per cent) of all isolates with Salmonella spp. and Proteus vulgaris predominating. All the bacterial isolates in this study were sensitive to ofloxacin and most were sensitive to the antibiotics commonly employed in the treatment of infections caused by these organisms. However, many of both Grampositive and Gram-negative isolates in this study were resistant to cotrimoxazole. The study highlights the high prevalence of bacterial infections (localized or systemic) among young infants. It also shows that Gram-positive organisms, the principal aetiologic agents, were sensitive to commonly used antibiotics. It is recommended that genticin and cloxacillin or erythromycin should be used as the first-line antibiotics in the treatment of young infants with bacterial infections in Ile-Ife, Nigeria.


    • 25 June 2004
      • Vol. 49, 74-8

    Paediatric HIV/AIDS in Ile-Ife, Nigeria.

    by E A Adejuyigbe, O Oyelami, O Onayemi, M A Durosinmi

    To determine the clinical features, modes of transmission and outcome of HIV infection in children. A descriptive study involving prospective HIV antibody screening. Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria, a referral centre. Four hundred and one consecutive children aged three days to 17 years presenting with features of immunosuppression from January 1996 to October 2001. HIV seroprevalence and outcome in infected children. Twenty percent of the children studied were HIV seropositive. More females than males were HIV seropositive (p = 0.004). The probable mode of infection was vertical in 66, blood transfusion in 12 and sexual contacts in four; two children whose mothers were HIV seropositive had previously been transfused with unscreened blood. Of the presenting clinical features, weight loss or failure to thrive, persistent diarrhoea, and skin diseases were highly sensitive and specific with high positive predictive values. Marasmus was the only type of protein energy malnutrition seen in the infected children. Seven patients were discharged against medical advice and 26 were lost to follow up. Thirty seven (46.3%) died within four months of diagnosis mainly from pneumonia and septicaemia. Four patients are still being followed up and only one is receiving antiretroviral drugs. HIV infection is a cause of morbidity and mortality in Nigerian children and the main mode of infection is vertical. The presence of any combination of persistent diarrhoea, weight loss/failure to thrive and skin manifestations should arouse suspicion and could be used as a screening test for symptomatic HIV infection in Nigerian children.


  • Sociodemographic characteristics of HIV-positive mother-child pairs in Ile-Ife, Nigeria

    by E. A. Adejuyigbe, O. B. Fasubaa, A. A. Onayade

    This study was designed to identify sociodemographic characteristics of HIV-positive mother-child pairs in the southwest of Nigeria. The aim was to identify factors that will be helpful in designing initiatives for preventing mother to child transmission (MTCT) of the virus. It was a hospital-based, case-control study carried out at the Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria from August 2000 to July 2002. Eligible mother-child pairs identified at the paediatric department, who consented to participate in the study, were interviewed using semi-structured questionnaires and screened for HIV seropositivity. Ninety-three (46.7%) of 199 mother-child pairs were HIV-positive. When compared with the 106 HIV-negative mothers, the HIV-positive mothers were younger, unemployed, had earlier sexual exposure, lower education and were married to polygynous spouses. It is recommended that initiatives designed to reduce MTCT of the HIV virus in the southwest of Nigeria should include education and improvement of the economic status of female adolescents; promotion of cultural practices such as virginity until marriage while discouraging polygyny and early marriage. Health education on prevention of HIV infection should target potential mothers and their partners.